Cite
APA Citation
Lipsyc-Sharf, M., Ou, F., Yurgelun, M. B., Rubinson, D. A., Schrag, D., Dakhil, S. R., Stella, P. J., Weckstein, D. J., Wender, D. B., Faggen, M., Zemla, T. J., Heying, E. N., Schuetz, S. R., Noble, S., Meyerhardt, J. A., Bekaii-Saab, T., Fuchs, C. S., & Ng, K. (2022). cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial. Oncologist, 27, 292–298. http://access.bl.uk/ark:/81055/vdc_100180188145.0x00005a